A CTO's Journey Into Continuous Biomanufacturing
At a recent Evaluating BioPharma virtual event, moderator John Bonham-Carter asked Chris Hwang, chief technical officer at Transcenta Holding Ltd.,...
Source: pharmaceuticalonline.com
Stay updated with breaking news from Evaluating Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At a recent Evaluating BioPharma virtual event, moderator John Bonham-Carter asked Chris Hwang, chief technical officer at Transcenta Holding Ltd.,...
Recently, Immunovant was working on a low demand fc fusion protein that was produced in a small number of lots with a very small clinical history.